About Immunetic
Immunetic is a Healthcare company based in Delhi (India) founded in 2008. It manufactures SPF eggs and purified serum for biotechnology and diagnostic uses. It operates on a B2B and Manufacturing model in Healthcare and Agriculture sectors. The company has 40 employees. Its Indian entity Immunetic Lifesciences Private Limited reported revenue of ₹13.68 Cr. Immunetic offers products and services including SPF Eggs and Purified Chicken Serum. Its focus areas include Diagnostics, Virology, Egg-based Products and Life Sciences. Its competitors include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus and 4 more; 2 of its 9 listed competitors have raised funding.
Company details
Immunetic Lifesciences is a biotechnology company specializing in producing Specified Pathogen Free (SPF) Embryonated Eggs and Purified Chicken Serum. They operate a modern facility in Himachal Pradesh, India, with a registered office in New Delhi. The company focuses on quality management and laboratory services for downstream virology and diagnostic products, employing stringent processes to ensure product integrity. They serve sectors requiring high-quality animal-derived materials for research and applications.
- Headquarters Delhi, India
- Employees 40
- SectorsHealthcareAgriculture
- Email••••••••
- Website immunetic.com
- Legal Name Immunetic Lifesciences Private Limited
- Date of Incorporation 14 Aug, 2008
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹13.68 Cr
FY 2025 · +42% YoY
- Net Profit₹3.70 Cr
FY 2025 · 27% margin
- EBITDA₹6.76 Cr
FY 2025 · 49% margin
- Employee Count40
Associated legal entities of Immunetic
Immunetic is associated with 2 registered companies on The Company Check; the primary company is Immunetic Lifesciences Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Immunetic Lifesciences Private Limited CIN U29297DL2008PTC182062 | Active | 14 Aug 2008 | New Delhi, Delhi | ₹13.7 Cr | 40 | 3 | View details |
| Indovax Private Limited CIN U74899DL1986PTC024582 | Active | 23 Jun 1986 | New Delhi, Delhi | ₹105 Cr | 251 | 3 | View details |
Products & Services of Immunetic
Immunetic offers a comprehensive portfolio of products and services, including SPF Eggs and Purified Chicken Serum.
Used as starting material for virology and diagnostic applications.
Purified serum for laboratory and research biotechnology needs.
Board of directors of Immunetic Lifesciences Private Limited (Immunetic)
Immunetic Lifesciences Private Limited is the primary company behind Immunetic. The boards of the 2 registered companies of Immunetic currently have 3 directors; the longest-serving is Rahul Kapur, appointed in 2008. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahul Kapur DIN 00020624 | Director | 14 Aug 2008 | 18 yrs 2 mo | Immunetic Lifesciences Private Limited, Indovax Private Limited |
| Deepak Kapur DIN 00393080 | Director | 14 Aug 2008 | 18 yrs 2 mo | Immunetic Lifesciences Private Limited, Indovax Private Limited |
| Vinod Somnath Kapur DIN 00054739 | Director | 07 Aug 2017 | 9 yrs 2 mo | Immunetic Lifesciences Private Limited, Indovax Private Limited |
Financials of Immunetic
Figures of Immunetic Lifesciences Private Limited, the primary company behind Immunetic, for FY 2025. Revenue was ₹13.68 Cr (+42% year on year). Net profit was ₹3.70 Cr (27% margin). EBITDA was ₹6.76 Cr (49% margin). Revenue has grown at a compounded annual rate of +3% over three years and +11% over five years.
- ₹13.68 CrRevenue · FY 2025 · +42% YoY
- ₹3.70 CrNet profit · 27% margin
- ₹6.76 CrEBITDA · 49% margin
- ₹4.91 CrPaid-up capital
- 40Employees (provident fund records)
- +3%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Immunetic Lifesciences Private Limited are on its company page.
Detailed financial statements for Immunetic
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Immunetic
Immunetic has 9 listed competitors in our database, 2 of them funded. They include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas | |
| cms.net.cn | 1992 | Shenzhen, China | – | – | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. |
Detailed competitors of Immunetic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
10 companies that operate in the same segment as Immunetic (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | 172 | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | 329 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Immunetic
Immunetic was founded in 2008.
Immunetic is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Immunetic has 40 employees.
The primary company behind Immunetic, Immunetic Lifesciences Private Limited, reported revenue of ₹13.68 Cr for FY 2025, up 42% year on year.
Immunetic Lifesciences is a biotechnology company specializing in producing Specified Pathogen Free (SPF) Embryonated Eggs and Purified Chicken Serum. They operate a modern facility in Himachal Pradesh, India, with a registered office in New Delhi. The company focuses on quality management and laboratory services for downstream virology and diagnostic products, employing stringent processes to ensure product integrity. They serve sectors requiring high-quality animal-derived materials for research and applications.
Immunetic's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Immunetic offers SPF Eggs and Purified Chicken Serum.
Immunetic is associated with 2 legal entities: Immunetic Lifesciences Private Limited, Indovax Private Limited.
The legal entities of Immunetic currently have 3 directors, including Rahul Kapur, Vinod Somnath Kapur, Deepak Kapur.